Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-08-012399
Filing Date
2008-02-22
Accepted
2008-02-22 13:29:00
Documents
1
Period of Report
2008-02-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 17354
  Complete submission text file 0001209191-08-012399.txt   19363
Mailing Address 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142 6176792000
BIOGEN IDEC INC. (Issuer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BIOGEN IDEC INC. 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address 617-679-2803
Clancy Paul J (Reporting) CIK: 0001409601 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19311 | Film No.: 08635659